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Abstract: Two coumarins, scopoletin (1) and isoscopoletin (2), two simple phe-
nolic acids, protocatechuic acid (3) and isovanillic acid (4) and one flavonoid, 
eriodictyol (5) were isolated from the aerial parts of Centaurea spruneri. The 
structure of the compounds was established by spectroscopic methods. The in 
vitro antimicrobial activity of the isolated compounds was tested against eight 
bacteria and eight fungal species, using a microdilution method. All com-
pounds tested showed moderate antibacterial and antifungal activities. Their 
minimum inhibitory concentrations were in the range 0.655–2.38 µmol ml-1 
and their minimal bactericidal concentrations ranged from 0.694 to 4.15 µmol 
ml-1 against the tested bacterial species. All compounds showed fungistatic 
activity at 0.259–2.38 µmol ml-1 and fungicidal at 0.69–2.6 µmol ml-1 against 
all fungi tested. 
Keywords: Centaurea spruneri; polyphenols; antibacterial activity; antifungal 
activity. 
INTRODUCTION 
The genus Centaurea L., with nearly 500 species, is mainly distributed 
around the Mediterranean area and in western Asia.1 It has been the subject of 
many chemical investigations, which led to the isolation of various types of com-
pounds, such as sesquiterpene lactones, being the most abundant group, flavo-
noids, lignans, nor-isoprenoids and volatile constituents. Previous investigations 
revealed a large number of Centaurea species possessing biologically active 
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compounds.2–15 Sesquiterpene lactones isolated from C. aschaia,2 C. thessala 
subsp. drakiensis,3 C. attica,3 C. deusta,4 C. chilensis,5 and C. nicolai6 were found 
to possess strong antifungal activity, while those isolated from C. spinosa pos-
sessed a slight inhibitory effect against Gram-positive bacteria.7 In addition, fla-
vonoids from C. raphanina spp. mixta showed moderate antifungal activity,8 while 
flavonoids from C. floccosa9 were effective against Gram-positive bacteria.  
As a continuation of research on Centaurea species,2–4,7,8,10–17 the second-
ary metabolites of C. spruneri are reported herein. 
C. spruneri Boiss. & Heldr. is a perennial species flowering rather late in 
summer, which grows wild in Greece and Albania. It is classified in the section 
Acrocentron (Cass.) DC.1 Hitherto, the volatile constituents of the aerial parts 
were investigated, which were mainly represented by terpenoids and homologous 
series of alkanes, alkenes, aliphatic alcohols and related aldehydes, as well as 
fatty acids and fatty acid methyl esters.16 The present study concerns the non-vo-
latile constituents of the plant. The evaluation of the antimicrobial activity of the 
isolated compounds was also investigated. 
EXPERIMENTAL 
Plant material 
The plant was collected from the margins of cultivated fields on the foothills of Mt. Pa-
teras (Attiki), 38° 6’ N, 23° 14’ E, c. 400–500 m, in July, 1998. A voucher specimen of the 
plant is kept in the Herbarium of the University of Patras (UPA) under the number: Cons-
tantinidis 2216. 
General procedure 
The structures of the isolated compounds were deduced by spectroscopic methods. The 
UV spectra were recorded on a Shimadzu UV-160A spectrophotometer, according to Mabry 
et al.18 The IR spectra were obtained on a Perkin-Elmer Paragon 500 FT-IR spectrophoto-
meter. The 1D and 2D NMR spectra were recorded using Bruker DRX 400 and Bruker AC 
200 spectrometers. COSY, HMQC, HSQC, HMBC, and NOESY (mixing time 950 ms) were 
performed using standard Bruker micro programs. Vacuum liquid chromatography (VLC) was 
performed on silica gel (Merck, Art. 9385) and column chromatography on silica gel (SDS, 
Art. 2050044), using solvent mixtures indicated in each case. Reversed-phase chromatography 
was carried out on JASCO HPLC system equipped with a UV detector; preparative HPLC 
was performed using a C18 25 cm×10 mm Kromasil column. Fractionations were always mo-
nitored by 1H-NMR and TLC on silica gel 60 F-254 (Merck, Art. 5554) and cellulose (Merck, 
Art. 5552) with visualization under UV radiation (254 and 365 nm) and spraying with anisal-
dehyde–sulfuric acid reagent on silica gel and Neu’ s reagent on cellulose.19  
Extraction and isolation of the bioactive compounds 
The fresh plant material (2.26 kg) was ground finely and extracted successively at room 
temperature with cyclohexane–Et2O–MeOH (1:1:1) and MeOH–H2O (5:1). The non-polar 
extract was washed with brine; the aqueous layer was re-extracted with EtOAc and the 
organic layer dried with Na2SO4 and concentrated under reduced pressure. The latter residue 
(6.73 g) was pre-fractionated by VLC on silica gel (10.0 cm×8.0 cm), using cyclohexane– 
–EtOAc–Me2CO mixtures of increasing polarity as eluents to give 12 fractions (A1–A12). 
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Column chromatography over silica gel (15 cm×1.0 cm) of fraction A5 (92.7 mg; eluted with 
EtOAc, 100 %) afforded 12 fractions (B1–B12). Fraction B11 (26.7 mg; eluted with cyclo-
hexane–CH2Cl2, 30:70) was subjected to HPLC (MeOH–H2O with 2 % AcOH, 4:6) and af-
forded compounds 4 (1.1 mg; tR 11.4 min) and 5 (0.9 mg; tR 89.1 min). Fraction A6 (116.6 
mg; eluted with EtOAc–Me2CO, 90:10) was subjected to column chromatography over silica 
gel (12 cm×1.5 cm) and afforded 11 fractions (C1–C11). Further purification of fraction C8 
(64.4 mg; eluted with cyclohexane–CH2Cl2, 50:50) by HPLC (MeOH–H2O with 2 % AcOH, 
4:6) yielded compounds 1 (3.1 mg; tR 22.6 min) and 5 (0.6 mg; tR 49.1 min). Column chroma-
tography over silica gel (12 cm×1.5 cm) of fraction A7 (274.3 mg; eluted with EtOAc– 
–Me2CO, 75:25) afforded 10 fractions (D1–D10). Fraction D8 (64.0 mg; eluted with cyclo-
hexane–EtOAc, 30:70) was subjected to HPLC (MeOH–H2O with 2 % AcOH, 4:6) and af-
forded compounds 2 (3.0 mg; tR 22.8 min), 3 (2.0 mg; tR 13.9 min) and 5 (2.7 mg; tR 78.3 min). 
Antimicrobial activity 
The following Gram-negative bacteria were used: Escherichia coli (ATCC 35210), Pro-
teus mirabilis (clinically isolated), Pseudomonas aeruginosa (ATCC 27853) and Salmonella 
typhimurium (ATCC 13311); and the following Gram-positive bacteria: Bacillus cereus (clini-
cally isolated), Micrococcus flavus (ATCC 10240), Listeria monocytogenes (NCTC 7973) and 
Staphylococcus aureus (ATCC 6538). For the antifungal bioassays, eight fungi were used: As-
pergillus niger (ATCC6275), Aspergillus versicolor (ATCC11730), Aspergillus flavus (ATCC 
9170), Aspergillus fumigatus (clinical strain), Candida albicans (clinical strain) Penicillium 
funiculosum (ATCC10509), Penicillium ochrochloron (ATCC9112) and Trichoderma viride 
(IAM5061). The organisms were obtained from the Mycological Laboratory, Department of 
Plant Physiology, Institute for Biological Research “Siniša Stanković”, Belgrade, Serbia and 
the Institute of Public Health of Serbia “Dr Milan Jovanović Batut”. The micromycetes were 
maintained on malt agar (Torlak, Serbia) and the cultures were stored at 4 °C and sub-cultured 
once a month.20 In order to investigate the antibacterial and antifungal activity of the isolated 
compounds, a modified microdilution technique was used for both activities.21,22 Bacterial 
species were cultured overnight at 37 °C in tryptic soy broth medium (Biolife, Italy). The 
spore suspension was adjusted with sterile saline to a concentration of approximately 1.0×105 
spores in a final volume of 100 μL per well. The inocula were stored at 4 °C for further use. 
Dilutions of the inocula were cultured on Müller–Hinton agar for bacteria and solid malt agar 
for fungi to verify the absence of contamination and to check the validity of the inoculum. The 
compounds investigated were dissolved in DMSO (0.1–1 μg mL-1) and added in the broth me-
dium (bacteria)/broth malt medium (fungi) with inocula. The minimum inhibitory concen-
tration (MIC) values were determined by a serial dilution technique using 96-well micro titer 
plates. The micro plates were incubated for 48 h at 37 °C (bacteria) or 72 h at 28 °C (fungi). 
For the fungi, the lowest concentration without visible growth (using a binocular microscope) 
was defined as the MIC. For the bacteria, the following day, 50 μL of 0.2 mg mL-1 solution of 
INT (p-iodonitrotetrazolium violet) was added, and the plates were returned to the incubator 
for at least 30 min to ensure adequate color reaction. Inhibition of growth was indicated by a 
clear solution or a definite decrease in the color reaction. This value was taken as the MIC va-
lue for the bacteria.23 The minimum bactericidal concentration (MBC) and minimum fungi-
cidal concentration (MFC) were determined by serial sub-cultivation of a 2 μL sample into 
microtiter plates containing 100 μL of broth per well and further incubation for 48 h at 37 °C 
or 72 h at 28 °C for the bacteria and fungi, respectively. The lowest concentration with no vi-
sible growth was defined as the MBC or MFC, respectively, indicating 99.5 % killing of the 
original inoculum.20 DMSO was used as the negative control, while the antibiotics strepto-
__________________________________________________________________________________________________________________________
2011 Copyright (CC) SCS
Available online at www.shd.org.rs/JSCS/
30 ĆIRIĆ et al. 
mycin and amoxicillin and the commercial fungicides bifonazole and ketokonazole were used 
as the positive controls (0.1–5 μL mL-1). All experiments were performed in triplicate.  
RESULTS AND DISCUSSION 
The structures of the isolated compounds are given in Fig 1. Their 
spectroscopic data were according to the literature.18,24,25 
       
            
Fig. 1. Structures of the isolated compounds 1–5 (A–D, respectively). 
The results for the antibacterial activity of compounds 1–5 are shown in 
Table I. The tested compounds possessed moderate antibacterial activity against 
all the tested bacterial species. The best results were obtained with compound 3, 
which showed the strongest antibacterial activity with MIC values of 0.65–1.3 
µmol ml–1 and MBC values of 1.3–2.6 µmol ml–1. Compound 4 exhibited the 
lowest antibacterial activity, with MIC and MBC values in the range 1.19–2.38 
µmol ml–1. B. cereus was the most sensitive bacterial species (MIC 0.65–1.19 
µmol ml–1), while L. monocytogenes was the most resistant species (MIC 1.30– 
–2.38 µmol ml–1). 
The results from the antifungal assay are summarized in Table II. Compound 
5 possessed the best antifungal activity, with MIC and MFC values in the range 
0.694–1.388 µmol ml–1, while compound 3 showed the lowest antifungal acti-
vity. This latter compound inhibited fungal growth at 0.65–1.3 µmol ml–1, while 
fungicidal activity was achieved at 1.3–2.6 µmol ml–1. The majority of the com-
pounds showed the worst activity against A. flavus, while C. albicans was the 
most sensitive species. The commercial drugs possessed lower or similar anti-
fungal activity as the tested compounds, with MIC values of 0.322–0.644 µmol 
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ml–1 and MFC values of 0.483–0.806 µmol ml–1 for bifonazole, and MIC values 
of 0.376–4.70 µmol ml–1 and MFC values of 0.64–5.64 µmol ml–1 for ketoko-
nazole. Although compound 3 showed the lowest antifungal activity, it exhibited 
the strongest antibacterial activity. In an effort to explain the different activity 
profiles of this compound, it was found that phenolic compounds with more hyd-
roxyl groups possess better antibacterial activity,26 while the antifungal activity 
was ascribed to the absence of polar groups in the molecule.27,28 
TABLE I. Minimum inhibitory and bactericidal concentrations (MIC and MBC / 10-2 µmol 
ml–1, 1st and 2nd row for each bacterium, respectively) of compounds 1–5 
Bacterium 1 2 3 4 5 Streptomycina Amoxicillina 
Bacillus 
cereus  
103.8±0.6 
103.8±0.6 
103.8±0.6
103.8±0.6
65.0±0 
130.0±0.6
119.0±1.5
119.0±1.5
69.4±0.3 
69.4±0.3 
4.3±0.3 
8.6±1.2 
27.4±0.6 
54.8±1.7 
Micrococcus 
flavus  
103.8±0.6 
207.6±1.2 
103.8±0.6
207.6±1.2
130.0±0.6
260.0±1.0
119.0±1.0
238.0±1.0
69.4±0.3 
277.6±1.2
8.6±1.2 
17.2±0.3 
6.9±0.3 
13.7±0.3 
Staphylococcus
aureus 
103.8±0.6 
207.6±1.2 
207.6±1.2
415.2±1.7
130.0±0.6
260.0±1.0
119.0±1.5
238.0±1.0
69.4±0.3 
277.6±1.2
17.2±0.3 
34.4±0.3 
6.9±0.3 
13.7±0.3 
Listeria 
monocytogenes
207.6±1.2 
207.6±1.2 
207.6±1.2
415.2±1.7
130.0±0.6
260.0±1.0
238.0±2.0
238.0±2.0
138.8±0.6
277.6±1.2
34.4±0.3 
68.8±0.6 
27.4±0.6 
54.8±0.6 
Escherichia 
coli 
103.8±0.3 
103.8±0.3 
103.8±0.6
103.8±0.6
130.0±0.6
130.0±0.6
119.0±0.6
119.0±0.6
69.4±0.3 
277.6±1.2
8.6±1.2 
17.2±0.3 
27.4±0.6 
54.8±1.7 
Pseudomonas 
aeruginosa 
103.8±0.6 
103.8±0.6 
103.8±0.3
103.8±0.3
65.0±0 
130.0±0.6
119.0±1.0
119.0±1.0
69.4±0.3 
277.6±2.1
17.2±0.3 
34.4±0.3 
13.7±0.6 
27.4±1.2 
Proteus 
mirabilis 
103.8±0.6 
207.6±1.7 
207.6±1.7
207.6±1.7
130.0±0.6
260.0±1.0
238.0±2.0
238.0±2.0
138.8±1.2
277.6±2.1
34.4±0.3 
68.8±1.2 
27.4±1.2 
54.8±1.7 
Salmonella 
typhimurium 
103.8±0.3 
103.8±0.3 
103.8±0.3
103.8±0.3
65.0±0 
130.0±0.6
119.0±1.5
119.0±1.5
69.4±0.3 
277.6±2.1
17.2±1.7 
34.4±1.2 
13.7±0.6 
27.4±1.2 
aPositive control, standard antibiotics 
Previous investigations revealed that the antimicrobial potential of Centau-
rea species is mainly due to their high content of sesquiterpene lactones.2–7,13,14 
Thus, sesquiterpene lactones such as cnicin, 4’-acetylcnicin, 8-(3-hydroxy-4-ace-
toxy-2-methylenebutanoyloxy)-4-epi-sonchucarpolide, 8α-O-(4,5-dihydroxytig-
loyloxy) esters of salonitenolide, 11,13-dihydromelitensin and 9-O-acetyl and 3- 
-O-deacetyl-9-O-acetyl derivatives of salograviolide A isolated from various of 
Centaurea species exhibited high or moderate antifungal activities against all the 
tested fungi with exception of Trichoderma viride, for which no inhibition was 
observed or with the worst activity.2,3,7 The sesquiterpene lactones: 8α-O-(4-
hydroxy-2-methylenebutanoyloxy)melitensine, melitensin, 11β,13-dihydrosaloni-
tenolide, 8α-hydroxy-11β,13-dihydro-4-epi-sonchucarpolide and 8α-hydroxy-
11β,13-dihydroonopordaldehyde isolated from the aerial parts of C. pullata 
showed greater antibacterial and antifungal activities than the positive controls 
used.14 The flavonoids, 6-methoxyapigenin, apigenin, 6-methoxyluteolyn-4’,7- 
-dimethylether, 6-methoxyluteolyn-3’-methylether, 6-methoxyluteolyn-3’,4’,7-
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trimethylether and C-glycosyl flavonoids characterized from the C. virgata, C. 
kilea and C. intermis exhibited inhibitory activities on fungal species, Gram-po-
sitive and Gram-negative bacteria. None of them was effective against Staphylo-
coccus aureus and S. epidermidis.29 The present study revealed that C. spruneri 
is a species poor in sesquiterpene lactones but rich in polyphenols, which were 
shown to possess antimicrobial activities against all the tested fungi, Gram-po-
sitive and Gram-negative bacteria. With respect to the antifungal potential of this 
latter group, the results obtained in the present study are in agreement with those 
previously reported for C. raphanina ssp. mixta8 and C. floccosa.9 
TABLE II. Minimum inhibitory and fungicidal concentrations (MIC and MFC / 10-2 µmol ml–1, 
1st and 2nd row for each fungus, respectively) of compounds 1–5 
Fungus 1 2 3 4 5 Bifonazolea Ketoconazolea 
Penicillium 
funiculosum 
103.8±0.3 
103.8±0.3 
103.8±0.3 
103.8±0.3 
130.0±1.0
130.0±1.0
119.0±1.0
119.0±1.0
69.4±0.6 
138.8±1.2 
64.4±0.3 
80.6±0.6 
37.6±0.6 
64.0±1.5 
Penicillium 
ochrochloron 
103.8±0.6 
207.6±0.6 
103.8±0.6 
207.6±0.6 
130.0±0.6
260.0±1.5
238.0±2.0
238.0±2.0
138.8±1.2 
138.8±1.2 
48.3±0.6 
64.4±1.7 
188.0±1.0 
188.0±1.0 
Trichoderma 
viride 
51.9±0.6 
103.8±0.6 
51.9±0.6 
103.8±0.6 
65.0±0 
130.0±1.0
59.0±0.6 
238.0±1.0
69.4±0.6 
138.8±0.6 
64.4±1.2 
80.6±0.6 
470.0±2.0 
564.0±1.5 
Aspergillus 
fumigatus 
103.8±0.6 
103.8±0.6 
103.8±0.6 
103.8±0.6 
130.0±0.6
260.0±1.0
238.0±1.0
238.0±2.0
138.8±0.6 
138.8±0.6 
48.3±0.6 
64.4±1.7 
37.6±0.6 
94.0±1.0 
Aspergillus 
niger 
103.8±0.6 
207.6±1.2 
103.8±0.6 
207.6±1.2 
130.0±1.0
260.0±1.5
238.0±1.0
238.0±1.0
138.8±0.6 
138.8±0.6 
48.3±0.6 
64.4±1.7 
37.6±0.6 
94.0±1.0 
Aspergillus 
flavus 
207.6±1.7 
207.6±1.7 
207.6±1.7 
207.6±1.7 
130.0±0.6
260.0±1.0
238.0±2.0
238.0±2.0
138.8±0.6 
138.8±0.6 
48.3±0.6 
64.4±1.7 
282.0±2.0 
376.0±1.0 
Aspergillus 
versicolor 
51.9±0.6 
207.6±1.2 
51.9±0.6 
207.6±1.2 
65.0±0 
260.0±1.5
59.0±0.6 
238.0±1.5
69.4±0.3 
138.8±1.2 
32.2±0.3 
64.4±1.2 
37.6±0.6 
94.0±1.0 
Candida 
albicans 
25.9±0.3 
103.8±0.3 
51.9±0.6 
103.8±0.6 
65.0±0 
130.0±0.6
59.0±0.6 
119.0±1.0
69.4±0.6 
69.4±0.6 
32.2±0.3 
48.3±0.6 
37.6±0.6 
94.0±1.0 
aPositive control, standard antibiotics 
Together with previously published data, the presented results indicate that 
Centaurea species possess biologically active compounds with different degrees 
of action. It can be seen that the growth of the tested microorganism responded 
differently to the investigated compounds, suggesting that different components 
may have different modes of action or that the metabolism of some microor-
ganisms are better able to overcome the effect of the compound or adapt to it. 
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И З В О Д  
АНТИМИКРОБНА АКТИВНОСТ СЕКУНДАРНИХ МЕТАБОЛИТА ИЗОЛОВАНИХ ИЗ 
Centaurea spruneri Boiss & Heldr. 
AНА ЋИРИЋ1, ANASTASIA KARIOTI2,3, JAСМИНА ГЛАМОЧЛИЈА1, MAРИНА СОКОВИЋ1 и HELEN SKALTSA2 
1Odeqewe za biqnu fiziologiju, Mikolo{ka laboratorija, Institut za biolo{ka istra`ivawa "S. 
Stankovi}", Univerzitet u Beogradu, Bulevar despota Stefana 142, 11 000 Beograd, 
2Department of 
Pharmacognosy, School of Pharmacy, University of Athens, Panepistimiopolis, Zografou, 157 71, Athens, Greecе 
и 3Department of Pharmaceutical Sciences, University of Florence, via Ugo Schiff 6, 
Polo Scientifico, Sesto Fiorentino, 50019 Florence, Italy 
Из надзeмног дела Centaurea spruneri изолована су два кумарина скополетин (1) и изо-
скополетин (2), две просте фенолске киселине протокатехуинска киселина (3) и изовани-
линска киселина (4) и флавоноид ериодиктиол. Хемијске структуре познатих једињења су 
утврђене коришћењем 1D и 2D NMR, MS и UV спектроскопских анализа. У in vitro тесту за 
одређивање антимикробне активности изолованих једињења коришћена је микродилуциона 
метода. Добијена једињења тестирана су на по осам бактеријских и гљивичних врста. Сва је-
дињења су имала умерену антибактеријску и антифунгалну активност. Минимална инхиби-
торна концентрација тестираних једињења се кретала од 0,655 до 2,38 µmol ml-1, а мини-
мална бактерицидна концентрација 0,694–4,15 µmol ml-1. Tестирана једињења су показала 
фунгицидну активност од 0,259–2,38 µmol ml-1 и фунгистатичку 0,694–2,60 µmol ml-1, на све 
тестиране гљиве. 
(Примљено 27. јануара, ревидирано 19. маја 2010) 
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